Anticancer compounds and methods

Details Anticancer compounds and methods Anticancer compounds and methods

2006-12-12

2006-12-12

Borin, Michael (Department: 1631)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S330000

Reexamination Certificate

active

07148196

ABSTRACT:
The testing of tumor cells, including human tumors capable of metastases, in assays employing fibronectin-depleted substrates is described. Ex vivo induction of cells, including biopsied human cells, is performed with invasion-inducing agents. Additionally, anti-cancer chemotherapeutics are described. Specifically, chemotherapeutic agents which have anti-metastatic and anti-growth properties are described including non-peptide compositions of matter.

REFERENCES:
patent: 4016043 (1977-04-01), Schuurs et al.
patent: 4018653 (1977-04-01), Mennen et al.
patent: 4424279 (1984-01-01), Bohn et al.
patent: 5051448 (1991-09-01), Shashoua
patent: 5136023 (1992-08-01), Hashino et al.
patent: 5169862 (1992-12-01), Burke, Jr. et al.
patent: 5192746 (1993-03-01), Lobl et al.
patent: 5264358 (1993-11-01), Doersen et al.
patent: 5436221 (1995-07-01), Kitaguchi et al.
patent: 5492890 (1996-02-01), Ginsburg et al.
patent: 5523209 (1996-06-01), Ginsburg et al.
patent: 5539085 (1996-07-01), Bischoff et al.
patent: 5548062 (1996-08-01), Isoai et al.
patent: 5559103 (1996-09-01), Gaeta et al.
patent: 5576423 (1996-11-01), Aversa et al.
patent: WO 95/24471 (1995-09-01), None
patent: WO 96/12823 (1996-05-01), None
P. Calabresi and B.A. Chabner, “Antineoplastic Agents,”In: Goodman and Gilman; The Pharmacological Basis of Therapeutics(Pergamon Press, 8th Edition) (pp. 1209-1216).
J.H. Gerlach, et. al., “Multidrug Resistance,”Cancer Surveys, 5:25-46 (1986).
J.H. Goldie and Andrew J. Coldman, “The Genetic Orgin of Drug Resistance in Neoplasms: Implications for Systemic Therapy,”Cancer Research, 44:3643-653 (1984).
D. Livant et al., “Invasion of Selectively Permeable Sea Urchin Embryo Basement Membranes by Metastatic Tumor Cells, But Not By Their Normal Counterparts,”Cancer Research55:5085 (1995).
Bresalier et al., “The Laminin 1 Chain Ile-Lys-Val-Ala-Val (IKVAV)-Containing Peptide Promotes Liver Colonization by Human Colon Cancer Cells,”Cancer Research55:2476 (1995).
Eldred et al., “Orally Active Non-Peptide Fibrinogen Receptor (GpIIb/IIIa)Antagonists: Identification of 4-[4-[4-(Aminoiminomethyl) phenyl]-1-piperazinyl]-1-piperidineacetic Acid as a Long-Acting, Broad-Spectrum Antithrombotic Agent,”J. Med. Chem., 37:3882 (1994).
Ku et al., “Potent Non-Peptide Fibrinogen Receptor Antagonists Which Present An Alternative Pharmacophore,”J. Med. Chem., 38:9 (1995).
W.R. Pearson and D.J. Lipman, “Improved Tools For Biological Sequence Comparison,”Proc. Natl. Acad. Sci. (USA), 85:2444-2448 (1988).
D.J. Lipman and W.R. Pearson, “Rapid and Sensitive Protein Similarity Searches,”Science, 227:1435-1441 (1985).
Douillard and Hoffman, “Basic Facts about Lymphocytes Hybridomas,”Compendium of Immunologyvol. II, ed. by Schwartz, pp. 119-141 (1981).
G. Kohler and C. Milstein, “Continuous Cultures of Fused Cells Secreting Antibody of Predefined Specificity,”Nature, 256:495-497 (1975).
G. Kohler and C. Milstein, “Derivation of Specific Antibody-Producing Tissue Culture and Tumor Lines By Cell Fusion,”European Journal of Immunology, 6:511-519 (1976).
C.L. Reading, “Theory and Methods For Immunization in Culture and Monoclonal Antibody Production,”Journal of Immunological Methods, 53:261-291 (1982).
Ethier, S. P. et al., “Differential Isolation of Normal Luminal Mammary Epithelial Cells and Breast Cancer Cells from Primary and Metastatic Sites Using Selective Media,”Cancer Research, 53:627-635 (1993).
Stone, K. R. et al., “Isolation of a Human Prostate Carcinoma Cell Line (DU 145),”Int. J. Cancer, 21:274-281 (1978).
T.K. Gartner et al., “The Tetrapeptide Analogue of the Cell Attachement Site of Fibronectin Inhibitis Platelet Aggregation and Fibrinogen Binding to Activated Platelets,”The Journal of Biological Chemistry, 260:11891-11894.
N.S. Nicholson et al., “In Vitro and In Vivo Effects of a Peptide Mimetic (SC-47643) of RGD As An Antiplatelet and Antithrombotic Agent,”Thrombosis Research, 62:567-578 (1995).
M. Nomizu et al., “Multimeric Forms of Tyr-Ile-Gly-Ser-Arg (YIGSR) Peptide Enhance the Inhibition of Tumor Growth and Metastasis,”Cancer Research, 53:3459-3461 (1993.
I. Saiki et al., “Inhibition of the Metastasis of Murine Malignant Melanoma By Synthetic Polymeric Peptides Containing Core Sequences of Cell-Adhesive Molecules,”Cancer Research, 49:3815-3822 (1989).
R.H. Wenger et al. “Cloning of cDNA Coding For Connective Tissue Activating Peptide III From a Human Platelet-Derived AgtII Expression Library,”Blood, 73(6):1498-1503.
S. Aota, et al., “The short Amino Acid Sequence Pro-His-Ser-Arg-Asn in Human Firbronection Enhances Cell-adhesive Function,”J. of Biol. Chemistry, vol. 269,40:24756-24761 (1994).
S. Kumar et al., “Childhood kidney tumours: in vitro studies and natural history,”Virchows Arch, 405:95-111 (1984).
M. O. Dayhoff, “Atlas of Protein Sequence and Structure”Natl. Biomed. Res. Foundation, Wash. D.C. 5:96 (1972).
Z. Song et.al., “A Novel Cysteine-rich Sequence-specific DNA-binding Protein Interacts with the Conserved X-box Motif of the Human Major Histocompatibility Complex Class II Genes Via a Repeated Cys-His-Domain and Functions as a Transcriptional Repressor,”Journal of Experimental Medicine, 180:1763-1774 (1994).
H P. Hershey et. al., “Analysis of cloned cDNA and genomic sequences for phytochrome: complete amino acid sequences for two gene products expressed in etiolatedAvena,” Nucleic Acids Research, 13: 8543-8559 (1985).

Affiliated with

Also associated with

Rating

Anticancer compounds and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anticancer compounds and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anticancer compounds and methods will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3712955